Swedish firm Alligator Bioscience (STO: ATORX) has announced that Dr Sumeet Ambarkhane, chief medical officer, will be ...

The Trump administration's moves to reduce government funding for the US Food and Drug Administration (FDA) and other ...

Chinese biotech Akeso (HKEX: 9926) has reported encouraging early data from a Phase III trial of its bispecific antibody ...

China's burgeoning biotech R&D capabilities are attracting increasing international attention, with non-Western countries ...

Dizal Pharmaceutical will present new research findings on two of its innovative drugs - sunvozertinib and golidacitinib - at ...

The New Drug Application (NDA) for Tazverik (tazemetostat) has been granted conditional approval in China for the treatment ...

US healthcare giant Johnson & Johnson has announced manufacturing, research and development and technology investments of ...

US pharma major Johnson & Johnson (NYSE: JNJ) has won US approval for Tremfya (guselkumab) in the treatment of adults with ...

Monte Rosa Therapeutics, a US biotech developing novel molecular glue degrader (MGD)-based medicines, closed Thursday’s ...

The US Food and Drug Administration (FDA) has approved Swiss pharma giant Novartis’ (NOVN: VX) oral Fabhalta (iptacopan) for ...

US biotech Rhythm Pharmaceuticals (Nasdaq: RYTM) has reacquired the rights to its obesity treatment Imcivree (setmelanotide) ...

US biotech GRO Biosciences is weighing the way forward for its lead gout program following a quiet restructuring that saw a ...